Anhui Expressway Company Limited/ CNE000001DC4 /
2024-05-16 9:00:01 AM | Chg. -0.29 | Volume | Bid9:00:04 AM | Ask9:00:01 AM | High | Low |
---|---|---|---|---|---|---|
13.31CNY | -2.13% | 9.13 mill. Turnover: 122.46 mill. |
13.29Bid Size: 5,800 | 13.31Ask Size: 273,700 | 13.75 | 13.22 |
GlobeNewswire
2:15 PM
Hip-Hop Duo Flyana Boss Joins Musicians On Call & Men’s Wearhouse in Making Prom Memories With Pedia...
GlobeNewswire
2:15 PM
Claritas HealthTech Extends Claritas iPET™ capability with iPETcertum™ for Automated Lesion Detectio...
GlobeNewswire
2:15 PM
Imperial Petroleum Inc. Reports First Quarter 2024 Financial and Operating Results
GlobeNewswire
2:05 PM
LED Lighting and EV Charging Solutions Provider Orion Previews FY 2024 Results in Anticipation of it...
GlobeNewswire
2:05 PM
MatrixCare Joins Health Gorilla’s Qualified Health Information Network (QHIN) to Enhance Patient Dat...
GlobeNewswire
2:05 PM
NKGen Biotech Announces Upcoming Presentation on Autologous NK Cell Therapy at the 5th International...
GlobeNewswire
2:03 PM
Meltwater Integrates Influencer Marketing Analytics, Workflows Within Social Suite, in an Industry F...
GlobeNewswire
2:01 PM
Ardelyx Presents Additional Data at the NKF 2024 Spring Clinical Meetings on XPHOZAH® (tenapanor)
GlobeNewswire
2:01 PM
Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Allowance for Malaria Antibodies That Have Po...
GlobeNewswire
2:00 PM
Fortress Biotech to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company...
GlobeNewswire
2:00 PM
Allegro MicroSystems to Present at TD Cowen’s Technology, Media & Telecom Conference on May 29
GlobeNewswire
2:00 PM
Oragenics, Inc. Prepares Intranasal Pharmaceutical, ONP-002, for Phase II Concussion Trial
GlobeNewswire
2:00 PM
Akari Therapeutics Reports First Quarter 2024 Financial Results and Recent Highlights